Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

LEGENDARE

Financiado

Leveraging genomic discoveries and skeletal phenotyping to improve osteoporosis...

Leveraging genomic discoveries and skeletal phenotyping to improve osteoporosis patient care Osteoporosis is a silent, systemic skeletal disease leading to fragility fracture. While the deleterious consequences for the individual, their families and society are well established, the causes of the disease remain elusive. D... ver más

31/10/2026

ERASMUS MC

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-10-12

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2020-ADG: ERC ADVANCED GRANT

I+D

Cerrada hace 4 años

0% 100%

2 Participantes

ERASMUS MC

2.50M€ | Lider

GRAFTECH IBERICA, S.L.

520.65K€ | Participante

Proyectos interesantes

TED2021-131518B-C31 MODELOS PREDICTIVOS PARA LA ESTIMACION DEL RIESGO DE PERDIDA... 110K€ Cerrado

SAF2010-15707 BASES GENETICAS DE PATOLOGIAS OSEAS: OSTEOPOROSIS, ALTA MASA... 42K€ Cerrado

DPI2011-22413 DISEÑO Y DESAROLLO DE UNA HERRAMIENTA COMPUTACIONAL PARA LA... 97K€ Cerrado

SAF2014-56562-R IDENTIFICACION DE VARIANTES, GENERACION DE MODELOS Y ENSAYOS... 121K€ Cerrado

PID2019-108096RB-C21 APROXIMACIONES SISTEMICAS BASADAS EN ASOCIACIONES FENOTIPO-G... 121K€ Cerrado

NonInvasive Cortical Bone Microstructure Analysis A Health Technology Assessment of a breakthrough technology... 4M€ Cerrado

Últimas noticias

27-11-2024: Videojuegos y creaci... Se abre la línea de ayuda pública: Ayudas para la promoción del sector del videojuego, del pódcast y otras formas de creación digital

27-11-2024: DGIPYME En las últimas 48 horas el Organismo DGIPYME ha otorgado 1 concesiones

27-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 2 concesiones

Duración del proyecto: 60 meses Fecha Inicio: 2021-10-12
Fecha Fin: 2026-10-31

Presupuesto del proyecto 2M€

Descripción del proyecto Osteoporosis is a silent, systemic skeletal disease leading to fragility fracture. While the deleterious consequences for the individual, their families and society are well established, the causes of the disease remain elusive. Despite exhaustive clinical, epidemiological and genomic research, scarce understanding of the complex underlying disease mechanisms leading to bone fragility has hindered the improvement of clinical care. This LEGENDARE programme aims to implement a holistic integrative approach directed at discerning the underlying mechanistic pathways leading to bone fragility. The approach seeks translating genomic and imaging discoveries into meaningful clinical strategies to stratify risk; re-evaluate treatment indication; and ultimately, redefine (molecular) disease classification of patients with osteoporosis and other skeletal diseases. LEGENDARE will progress beyond the state-of-the-art by integrating genomic information from thousands of loci (genome regions) associated with musculoskeletal traits and other diseases, into optimized polygenic risk scores providing novel biological insight about skeletal disease. Skeletal research will be brought to a new level by enriching skeletal imaging with BIG DATA obtained with advanced whole-body EOS 3D X-rays. Approaching the whole skeleton as a unified organ will allow the unprecedented study of hidden relationships across bone compartments. Further, using artificial intelligence approaches, the complexity of the skeletal system will be modelled, integrating genomic, imaging and clinical data across epidemiological cohorts and patient settings. LEGENDARE will deliver knowledge on fundamental processes regulating skeletal fragility, unveiling new strategies for translational exploitation leading to improved clinical outcomes of osteoporosis patients. Discoveries will hold wider significance through potential spinoffs able to mitigate the societal impact of other diseases surging with bone fragility.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores